Cytodyn Inc (CYDY)

[3X Charm]

Let’s not get ahead of ourselves, like the pivot by NP to Philippines, Brazil, and India etc., is a “mater stroke”.

This is a necessary path due to poorly prepared and implemented trials in US. FDA is probably culpable, but CYDY has made it easy for the bureaucratic agency to turn its back on LL, by dropping the ball scientifically.

Let’s hope additional studies are properly powered and implemented so that the issue of approval is “forced” by irrefutable scientific proof. This has not yet been objectively achieved by this team.In the meantime, any revenue generated gives CYDY time to move the ball forward in HIV and hopefully cancer.

Unforced errors by management must stop now!